LifeTech Scientific Corporation (HKG:1302)
Hong Kong · Delayed Price · Currency is HKD 1.760
-0.040 (-2.22%)
Sep 26, 2025, 4:08 PM HKT
LifeTech Scientific Revenue
LifeTech Scientific had revenue of 676.71M CNY in the half year ending June 30, 2025, with 5.82% growth. This brings the company's revenue in the last twelve months to 1.33B, up 3.68% year-over-year. In the year 2024, LifeTech Scientific had annual revenue of 1.30B with 2.88% growth.
Revenue (ttm)
1.33B CNY
Revenue Growth
+3.68%
P/S Ratio
5.60
Revenue / Employee
951.67K CNY
Employees
1,395
Market Cap
8.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.30B | 36.52M | 2.88% |
| Dec 31, 2023 | 1.27B | 169.87M | 15.48% |
| Dec 31, 2022 | 1.10B | 171.98M | 18.59% |
| Dec 31, 2021 | 925.33M | 283.04M | 44.07% |
| Dec 31, 2020 | 642.30M | -26.58M | -3.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| JD Health International | 71.34B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |
LifeTech Scientific News
- 4 weeks ago - LifeTech Scientific Corporation reports 1H results - Seeking Alpha